Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Disrupted brain state dynamics in opioid and alcohol use disorder: attenuation by nicotine use
    Published on 2023-11-06
    3 years ago
  • Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making
    Published on 2023-10-31
    3 years ago
  • A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms
    Published on 2023-10-29
    3 years ago
  • Bed Nucleus of the Stria Terminalis (BNST) neurons containing the serotonin 5HT2c receptor modulate operant alcohol self-administration behavior in mice
    Published on 2023-10-26
    3 years ago
  • Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study
    Published on 2023-10-24
    3 years ago
  • Navigating the FDA regulatory landscape
    Published on 2023-10-18
    3 years ago
  • Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge
    Published on 2023-10-17
    3 years ago
« Previous 1 … 114 115 116 117 118 … 143 Next »
Journal of Psychopharmacology
  • Selective activation of D1 dopamine receptors exerts antidepressant-like activity in rats
    Published on 2020-10-09
    6 years ago
  • Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Published on 2020-09-10
    6 years ago
  • Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale
    Published on 2020-09-09
    6 years ago
  • Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
    Published on 2020-09-09
    6 years ago
  • Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
    Published on 2020-09-09
    6 years ago
  • The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
    Published on 2020-08-28
    6 years ago
  • The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction
    Published on 2020-08-28
    6 years ago
« Previous 1 … 114 115 116 117 118 … 154 Next »
European Neuropsychopharmacology
  • P.317 Psychosis in Parkinson’s disease
    Published on 2021-02-26
    6 years ago
  • P.318 Neurobiological marker and intervention for socio-communicative impairments in autism spectrum disorders
    Published on 2021-02-26
    6 years ago
  • P.309 Latent class growth modeling reveals two distinct pupillometric response profiles in a working memory task
    Published on 2021-02-26
    6 years ago
  • P.310 Effects of intranasal administration of the neuromodulator oxytocin on autonomic cardiac function
    Published on 2021-02-26
    6 years ago
  • P.311 Evaluation of serum vitamin B12, folate and ferritin levels in children and adolescents with anxiety disorders
    Published on 2021-02-26
    6 years ago
  • P.306 An exploration of the pro-cognitive potential of the 5-HT4 agonist, prucalopride, in the healthy human brain
    Published on 2021-02-26
    6 years ago
  • P.312 A multimetric systematic review of fMRI findings in patients with MDD receiving ECT
    Published on 2021-02-26
    6 years ago
« Previous 1 … 114 115 116 117 118 … 170 Next »

   Pharma Pub